Cited by 293GDF15 and Related BiomarkersMitochondrial Function and PathologyMetabolism and Genetic Disorders

Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders

Open access
Yatsuga, Shuichi, Fujita, Yasunori, Ishii, Akiko, Fukumoto, Yoshihiro, Arahata, Hajime, Kakuma, Tatsuyuki, Kojima, Toshio, Ito, Masafumi +3 more·2015·Annals of Neurology

Abstract

OBJECTIVE: The diagnosis of mitochondrial disorders (MDs) is occasionally difficult because patients often present with solitary, or a combination of, symptoms caused by each organ insufficiency, which may be the result of respiratory chain enzyme deficiency. Growth differentiation factor 15 (GDF-15) has been reported to be elevated in serum of patients with MDs. In this study, we investigated whether GDF-15 is a more useful biomarker for MDs than several conventional biomarkers. METHODS: We measured the serum levels of GDF-15 and fibroblast growth factor 21 (FGF-21), as well as other biomarkers, in 48 MD patients and in 146 healthy controls in Japan. GDF-15 and FGF-21 concentrations were measured by enzyme-linked immunosorbant assay and compared with lactate, pyruvate, creatine kinase, and the lactate-to-pyruvate ratio. We calculated sensitivity and specificity and also evaluated the correlation based on two rating scales, including the Newcastle Mitochondrial Disease Rating Scale (NMDAS). RESULTS: Mean GDF-15 concentration was 6-fold higher in MD patients compared to healthy controls (2,711 ± 2,459 pg/ml vs 462.5 ± 141.0 pg/mL; p < 0.001). Using a receiver operating characteristic curve, the area under the curve was significantly higher for GDF-15 than FGF-21 and other conventional biomarkers. Our date suggest that GDF-15 is the most useful biomarker for MDs of the biomarkers examined, and it is associated with MD severity. INTERPRETATION: Our results suggest that measurement of GDF-15 is the most useful first-line test to indicate the patients who have the mitochondrial respiratory chain deficiency.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.24506

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yatsuga, S., Fujita, Y., Ishii, A., Fukumoto, Y., Arahata, H., Kakuma, T., Kojima, T., Ito, M., Tanaka, M., Saiki, R., & Koga, Y.
Affiliations
  • Kurume University (JP)
  • Tokyo Metropolitan Institute of Gerontology (JP)
  • University of Tsukuba (JP)
  • Omuta hospital (JP)
  • Toyohashi University of Technology (JP)
Corresponding author
Koga, Yasutoshi
Venue
Annals of Neurology
Publisher
Wiley
Published
2015-10-14
Volume
78
Issue
5
Pages
814-823
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1903699046
Cited by
293
References
25
Citations by year
2026: 26 · 2025: 29 · 2024: 29 · 2023: 24 · 2022: 32 · 2021: 35 · 2020: 41 · 2019: 31 · 2018: 14 · 2017: 18 · 2016: 13 · 2013: 1
FWCI
12.59
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (publishedVersion)
  • Terrestrial Environment Research Center (University of Tsukuba) (submittedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology (MEXT) (25461571 (to Y.K.), 25860891 (to S.Y.), 25242062 (to M.T.))
  • The Ministry of Health, Labor and Welfare of Japan. (24-Nanchi-Ippan-005 (to Y.K.) for Research on Intractable Diseases)
Topics
  • Health Sciences › Medicine › Rheumatology › GDF15 and Related Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
growth differentiation factor 15, mitochondrial disease, biomarkers, FGF21, respiratory chain deficiency, serum biomarkers, disease severity, sensitivity and specificity
MeSH terms
Adolescent, Adult, Child, Creatine Kinase, Female, Fibroblast Growth Factors, Humans, Male, Middle Aged, ROC Curve, Biomarkers, MELAS Syndrome, Pyruvic Acid, Lactic Acid, Mitochondrial Diseases, Growth Differentiation Factor 15, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review